Imidazo[1,2-a]pyridine-3-acetic Acid Methyl Ester: A Key Pharmaceutical Intermediate

Unlock advancements in osteoporosis treatment with this vital organic compound, a cornerstone for Minodronic Acid synthesis.

Get a Quote & Sample

Advantages This Product Brings

Enabling Minodronic Acid Production

As a key Imidazo[1,2-a]pyridine-3-acetic acid methyl ester intermediate, this compound directly facilitates the efficient synthesis of Minodronic Acid, a crucial drug for treating bone disorders.

Versatility in Medicinal Chemistry

The unique structure of Methyl imidazo[1,2-a]pyridin-3-ylacetate offers significant versatility, allowing chemists to explore various drug discovery pathways and develop new therapeutic candidates.

High Purity and Consistency

With an assay of ≥98.0%, this chemical ensures high purity, which is essential for reliable and reproducible results in pharmaceutical research and development and fine chemical production.

Key Applications

Minodronic Acid Synthesis

This compound is indispensable as a precursor in the synthesis of Minodronic Acid, a third-generation bisphosphonate vital for treating osteoporosis and other bone-related conditions.

Pharmaceutical Research

The specific CAS 1244029-51-3 uses extend to broader pharmaceutical research, where its structure is leveraged for exploring new drug molecules and therapeutic targets.

Drug Discovery & Development

Its role in medicinal chemistry positions it as a valuable asset for drug discovery programs aiming to develop novel treatments for various diseases, building upon the known bioactivity of imidazo[1,2-a]pyridine derivatives.

Fine Chemical Production

Beyond pharmaceuticals, Imidazo[1,2-a]pyridine-3-acetic acid methyl ester is utilized in fine chemical production where its specific chemical properties are required for complex synthetic pathways.